Key facts
- This page summarizes Anthony Scott Praill's Form 4 filing for Kintara Therapeutics, Inc. (HURA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Aug 2022, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The Reporting Person was granted 240,087 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in 4 equal annual installments beginning on August 1, 2023.
Footnote F2
The option vests as to 25% on August 1, 2023 with the remainder to vest in 36 equal monthly installments thereafter.